Affymax Plunges, Amgen Hits High On Drug Recall
Shares of Affymax (AFFY) plunged 85% Monday after the biotech recalled its anemia drug due to safety concerns, sending rival Amgen's (AMGN) stock to a new high.
Tags:
Affymax Plunges, Amgen Hits High On Drug Recall,
Amgen Latest News